Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical CBD Cream for Hallux Disorders
NCT04103814Phase 3Terminated
- Sponsor
- Rush University Medical Center
- Start
- Oct 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hallux valgus and hallux rigidus comparing Mg-CBDa cream with Placebo cream (2 arms). Primary endpoints: Post-treatment Visual Analog System (VAS) Pain Score at 4 weeks and Weekly Foot Function Index at 4 weeks. Started Oct 2019; status: terminated.
02
Drugs
magnesium + cannabidiolic acid
03
Conditions
hallux valgushallux rigidus
Beyond the preview
Go deeper on NCT04103814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04103814.